Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 11


Results: 30
    1

    CORRIGENDUM.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 11, p. 1748, doi. 10.1111/1759-7714.14468
    Publication type:
    Article
    2

    CORRIGENDUM.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 11, p. 1747, doi. 10.1111/1759-7714.14467
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 11, p. 1676, doi. 10.1111/1759-7714.14442
    By:
    • How, Soon Hin;
    • Tho, Lye Mun;
    • Liam, Chong Kin;
    • Hasbullah, Harissa H.;
    • Ho, Gwo Fuang;
    • Muhammad Nor, Ibtisam;
    • Poh, Mau Ern;
    • Ho, Kean Fatt;
    • Thiagarajan, Muthukkumaran;
    • Samsudin, Azlina;
    • Omar, Azza;
    • Ong, Choo Khoon;
    • Pang, Yong Kek;
    • Soon, Sing Yang
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 11, p. 1611, doi. 10.1111/1759-7714.14428
    By:
    • Masuda, Takeshi;
    • Fujitaka, Kazunori;
    • Suzuki, Tomoko;
    • Hamai, Kosuke;
    • Matsumoto, Naoko;
    • Matsumura, Mirai;
    • Isoyama, Shoko;
    • Ueno, Sayaka;
    • Mito, Mineyo;
    • Yamaguchi, Kakuhiro;
    • Sakamoto, Shinjiro;
    • Kawano, Reo;
    • Masuda, Ken;
    • Nishino, Ryohei;
    • Ishikawa, Nobuhisa;
    • Yamasaki, Masahiro;
    • Hattori, Noboru
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Issue Information.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 11, p. 1543, doi. 10.1111/1759-7714.14025
    Publication type:
    Article